PMCID: PMC4811838 DOI: 10.1007/s40121-016-0105-2
Concomitant antibiotic use during treatment for Clostridium difficile infection (CDI) increases the risk of recurrence. Across a network of children's hospitals, 46% of patients treated for CDI received concomitant antibiotics for a median of 7 days. Concomitant antibiotic use was more common among patients with malignancies, and solid organ or bone marrow transplant. Unnecessary concomitant antibiotic use in CDI patients is a potential target for pediatric antimicrobial stewardship.
Infect Dis Ther
Clostridium difficile infection; Concomitant antibiotics; Pediatric; Children; Babies; C-diff
Stevens, Vanessa W.; Thurm, Cary; Schwab, Elyse M.; Kronman, Matthew P.; Gerber, Jeffrey S.; Shah, Samir S.; Newland, Jason G.; Courter, Joshua; Parker, Sarah; Brogan, Thomas V.; and Hersh, Adam L., "Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study." (2016). Manuscripts, Articles, Book Chapters and Other Papers. 280.